Not a Lexis Advance subscriber? Try it out for free.


Mealey's PI/Product Liability - Zantac Manufacturers Agree MDL Should Be Formed, Sent To New Jersey

WASHINGTON, D.C. - The current manufacturer of the over-the-counter heartburn drug Zantac and three former manufacturers on Nov. 27 told a federal judicial panel that they support the creation of a Zantac/ranitidine/N-nitrosodimethylamine (NDMA) multidistrict litigation (In Re: Zantac/Ranitidine NDMA Litigation, MDL Docket No. 2924, JPMDL).
Find full version on lexis Advance®